Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) was the recipient of some unusual options trading on Wednesday. Investors bought 51,813 call options on the company. This is an increase of approximately ...
David R. Epstein, a director at Tempus AI , Inc. (NASDAQ:TEM), recently sold 370 shares of the company's Class A Common Stock. The shares were sold on February 3, 2025, at an average price of $53.31 ...
Tempus AI , Inc. (NASDAQ: TEM )董事David R. Epstein近期出售了370股该公司A类普通股。这些股票于2025年2月3日以平均每股$53.31的价格售出,总价值约$19,724。此后,TEM股价已上涨至$69.18,这家市值$97.4亿的公司年初至今已实现105%的显著涨幅。 InvestingPro ...
TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the health-tech company completed its $600 million acquisition of Ambry Genetics.
The bank had suspended its rating and price target for Tempus during its $600 million acquisition of Ambry Genetics due to TD Securities' involvement in the deal.
The more significant driver of Tempus’ rally was the announcement of its new AI-enabled health app, Olivia. Designed as a personal health concierge, Olivia integrates patient data from over ...
Tempus AI shares surged more than 35% on Tuesday after former House Speaker Nancy Pelosi disclosed call options expiring in 2026. Several AI-related stocks are rising Wednesday after U.S ...